BioCardia, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Sunnyvale, CA
BCDA chart
What traders are saying about $BCDA
Latest postsBioCardia, Inc. news
- Warrants carry a 9.99% ownership cap for a BioCardia (BCDA) shareholder.
Stock Titan ·
- BioCardia to host Q3FY27 results call on November 12
scanx.trade ·
- BioCardia to Host Q3 2026 Financial Results and Corporate Update Conference Call on November 12, 2026
Yahoo Finance ·
- A live webcast will carry BioCardia's third-quarter results update on Nov. 12
Stock Titan ·
- META_TITLE_QUOTE
Yahoo Finance Australia ·
- BioCardia Inc expected to post a loss of 13 cents a share - Earnings Preview
TradingView ·
- BioCardia's CardiAMP Completes Japan Pre-Market Consultation, First Cardiac Cell Therapy to Do So
Tech Times ·
- BioCardia completes CardiAMP clinical consultation process with Japan PMDA
TipRanks ·
- Form 8K Biocardia Inc For: 6 November By Investing.com
Investing.com Canada ·
- BioCardia advances toward Japan approval for Ca...
Pluang ·
- BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing Approval Application
Yahoo Finance ·
- A heart failure cell therapy could reach its first patients in Japan in 2028
Stock Titan ·
BioCardia, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.2M | -$7.9M | -$11.6M | -$11.9M |
| Total assets (year end) | $3.4M | $3.7M | $3.0M | $9.8M |
| Cash and equivalents (year end) | $2.5M | $2.4M | $1.1M | $7.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BioCardia, Inc.
- Ticker
- BCDA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Sunnyvale, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 925741
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC
Frequently asked questions
What exchange is BioCardia, Inc. listed on?
BioCardia, Inc. trades on the Nasdaq under the ticker symbol BCDA.
What industry is BioCardia, Inc. in?
BioCardia, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is BioCardia, Inc. headquartered?
BioCardia, Inc.'s business address on file with the SEC is in Sunnyvale, CA.
When does BioCardia, Inc.'s fiscal year end?
BioCardia, Inc.'s fiscal year ends on December 31.
How much revenue did BioCardia, Inc. report?
BioCardia, Inc. reported $479,000 in revenue for calendar year 2017, according to its SEC filings.